液体活检在结直肠癌诊断中的应用进展

doi:10.11904/j.issn.1002-3070.2020.04.012

Abstract

Abstract: Colorectal cancer(CRC),as the third most common cancer in the world,is one of important cause of human death.At present,the diagnostic methods for CRC are still being improved.Liquid biopsy,as an emerging non-invasive biopsy technology,has attracted widespread attention.Liquid biopsy mainly analyzes specific components of biological source liquid,which mainly include circulating tumor cells,circulating tumor DNA,cell free DNA,exosomes,tumor-educated platelets,and circulating tumor-associated microparticles.This article reviews the latest application research of the above biological source liquid specific components in the diagnosis of CRC.

Key words: Colorectal cancer, Liquid biopsy, Diagnosis

CLC Number:

LI Hengzhen, ZHANG Yanqiao. Application progress of liquid biopsy in the diagnosis of colorectal cancer[J]. Journal of Practical Oncology, 2020, 34(4): 357-361.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/10.11904/j.issn.1002-3070.2020.04.012

http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/Y2020/V34/I4/357

References

1 Arnold M,Sierra MS,Laversanne M,et al.Global patterns and trends in colorectal cancer incidence and mortality[J].Gut,2016,66(4):683-691.
2 Simon K.Colorectal cancer development and advances in screening[J].Clin Interv Aging,2016,11:967-976.
3 Scholer LV,Reinert T,Orntoft MW,et al.Clinical implications of monitoring circulating tumor DNA in patients with colorectal cancer[J].Clin Cancer Res,2017,23(18):5437-5445.
4 Wan JCM,Massie C,Garcia-Corbacho J,et al.Liquid biopsies come of age:towards implementation of circulating tumour DNA[J].Nat Rev Cancer,2017,17(4):223-238.
5 Stroun M,Maurice P,Vasioukhin V,et al.The origin and mechanism of circulating DNA[J].Ann N Y Acad Sci,2010,906(1):161-168.
6 Yue C,Jiang Y,Li P,et al.Dynamic change of PD-L1 expression on circulating tumor cells in advanced solid tumor patients undergoing PD-1 blockade therapy[J].Oncoimmunology,2018,7(7):e1438111.
7 Siravegna G,Marsoni S,Siena S,et al.Integrating liquid biopsies into the management of cancer[J].Nat Rev Clin Oncol,2017,14(9):531-548.
8 崔雪阳,邢承忠.液体活检在结直肠癌领域的研究及应用现状[J].实用肿瘤学杂志,2018,32(4):85-88.
9 Lee JH,Long GV,Menzies AM,et al.Association between circulating tumor DNA and pseudoprogression in patients with metastatic melanoma treated with anti-programmed cell death 1 antibodies[J].JAMA Oncol,2018,4(5):717-721.
10 Olsson E,Winter C,George A,et al.Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease[J].Embo Mol Med,2015,7(8):1034-1047.
11 Parkinson CA,Gale D,Piskorz AM,et al.Exploratory analysis of TP53 mutations in circulating tumour DNA as biomarkers of treatment response for patients with relapsed high-grade serous ovarian carcinoma:a retrospective study[J].PLoS Med,2016,13(12):e1002198.
12 Luo HY,Zhao Q,Wei W,et al.Circulating tumor DNA methylation profiles enable early diagnosis,prognosis prediction,and screening for colorectal cancer[J].Sci Transl Med,2020,12(524):7533.
13 Wan N,Weinberg D,Liu TY,et al.Machine learning enables detection of early-stage colorectal cancer by whole-genome sequencing of plasma cell-free DNA[J].BMC Cancer,2019,19(1):832.
14 Church TR,Wandell M,Lofton-Day C,et al.Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer[J].Gut,2014,63(2):317-325.
15 Ludwig AK,Giebel B.Exosomes:small vesicles participating in intercellular communication[J].Int J Biochem Cell Biol,2012,44(1):11-15.
16 Ogata-Kawata H,Izumiya M,Kurioka D,et al.Circulating exosomal microRNAs as biomarkers of colon cancer[J].PLoS One,2014,9(4):e92921.
17 Hu HY,Yu CH,Zhang HH,et al.Exosomal miR-1229 derived from colorectal cancer cells promotes angiogenesis by targeting HIPK2[J].Int J Biol Macromol,2019,132:470-477.
18 Fu F,Jiang W,Zhou L,et al.Circulating exosomal miR-17-5p and miR-92a-3p predict pathologic stage and grade of colorectal cancer[J].Transl Oncol,2018,11(2):221-232.
19 Uratani R,Toiyama Y,Kitajima T,et al.Diagnostic potential of cell-free and exosomal MicroRNAs in the identification of patients with high-risk colorectal adenomas[J].PLoS One,11(10):e0160722.
20 Barbagallo C,Brex D,Caponnetto A,et al.lncRNA UCA1,up regulated in CRC biopsies and downregulated in serum exosomes,controls mRNA expression by RNA-RNA interactions[J].Mol Ther Nucleic Acids,2018,12:229-241.
21 Cooke NM,Egan K,McFadden S,et al.Increased platelet reactivity in patients with late-stage metastatic cancer[J].Cancer Med,2013,2(4):564-570.
22 Best MG,Wesseling P,Wurdinger T.Tumor-educated platelets as a noninvasive biomarker source for cancer detection and progression monitoring[J].Cancer Res,2018,78(13):3407-3412.
23 Best MG,Vancura A,Wurdinger T.Platelet RNA as a circulating biomarker trove for cancer diagnostics[J].Thromb Haemost,2017,15(7):1295-1306.
24 Lin RJ,Afshar-Kharghan V,Schafer AI.Paraneoplastic thrombocytosis:the secrets of tumor self-promotion[J].Blood,2014,124(2):184-187.
25 Sabrkhany S,Kuijpers MJE,Van Kuijk SMJ,et al.A combination of platelet features allows detection of early-stage cancer[J].Eur J Cancer,2017,80:5-13.
26 Best MG,Sol N,Kooi I,et al.RNA-Seq of tumor-educated platelets enables blood-based pan-cancer,multiclass,and molecular pathway cancer diagnostics[J].Cancer Cell,2015,28(5):666-676.
27 Yang L,Jiang Q,Li DZ,et al.TIMP1 mRNA in tumor-educated platelets is diagnostic biomarker for colorectal cancer[J].Aging,2019,11(20):8998-9012.
28 Sol N,Wurdinger T.Platelet RNA signatures for the detection of cancer[J].Cancer Metastasis Rev,2017,36(2):263-272.
29 Piccin A,Murphy WG,Smith OP.Circulating microparticles:pathophysiology and clinical implications[J].Blood Rev,2007,21(3):157-171.
30 Van Doormaal FF,Kleinjan A,Di Nisio M,et al.Cell-derived microvesicles and cancer[J].Neth J Med,2009,67(7):266-273.
31 Rak J.Microparticles in cancer[J].Seminars Thromb Hemost,2010,36(8):888-906.
32 D'Souza-Schorey C,Clancy JW.Tumor-derived microvesicles:shedding light on novel microenvironment modulators and prospective cancer biomarkers[J].Genes Dev,2012,26(12):1287-1299.
33 Willms A,Müller C,Julich H,et al.Tumour-associated circulating microparticles:a novel liquid biopsy tool for screening and therapy monitoring of colorectal carcinoma and other epithelial neoplasia[J].Oncotarget,2016,7(21):30867-30875.

[1]	ZHAO Rencheng, LIN Zitang, YU Weijun, LEI Lin, LIU Zheng, XU Ying, GUO Yanfang, PENG Ji. Analysis of the prevalence of five cancer risks among permanent residents aged 40~74 years old in Baoan District,Shenzhen,2017—2019 [J]. Journal of Practical Oncology, 2020, 34(4): 315-320.
[2]	ZHANG Rui, LI Zhigao. Clinical research progress of mucinous breast cancer [J]. Journal of Practical Oncology, 2020, 34(4): 377-381.
[3]	ZHU Xiaoyun,ZHANG Yaning,MA Biping. Trend analysis of the death level and the probability of early death caused by colorectal cancer in Jinshan district,Shanghai,1980—2018 [J]. Journal of Practical Oncology, 2020, 34(3): 198-202.
[4]	LU Xuemei,LI Yuntao,AN Jinhui,JI Guozhong. The mechanism of lysophosphatidic acid in the development of colorectal cancer [J]. Journal of Practical Oncology, 2020, 34(3): 276-281.
[5]	HAN Shuling, FANG Lin, ZHANG Yanqiao. Thoughts on the diagnosis and treatment of patients with oncology after the corona virus disease 2019 epidemic [J]. Journal of Practical Oncology, 2020, 34(2): 97-99.
[6]	LI Bin, FENG Baoheng, YIN Fuxia, SU Wei. Establishment of a colorectal cancer xenograft model to study the bacterial infection in the intestine of mice and the mechanism of decitabine combined with cisplatin chemotherapy [J]. Journal of Practical Oncology, 2020, 34(2): 163-168.
[7]	ZENG Li, ZHUANG Shutong, DING Shihua, CHEN Chong, JIAO Lu, SUN Dayong. Molecular mechanisms of long non-coding RNA AFAP1-AS1 regulating the proliferation of colorectal cancer cells by PTEN/p-AKT signaling pathway [J]. Journal of Practical Oncology, 2020, 34(1): 11-16.
[8]	LIAO Daixiang, ZHENG Bo, ZHANG Yanbin, YU Junhui. Expression of RRBP1 and RABEX-5 proteins in colorectal cancer and their correlation with clinicopathological features and prognosis [J]. Journal of Practical Oncology, 2020, 34(1): 43-48.
[9]	ZHANG Jinglan, LIU Ruibao. Progress in local interventional therapy for colorectal cancer with liver metastasis [J]. Journal of Practical Oncology, 2020, 34(1): 79-82.
[10]	LI Zhijie, ZHAO Qi, WU Huaxing. Research progress in the effects of intestinal microbes on colorectal cancer patients by metagenomics [J]. Journal of Practical Oncology, 2020, 34(1): 93-96.
[11]	ZHANG Yiwei, SHI Jing, LIU Yupeng, CAO Liming, HU Fulan, ZHAO Yashuang. Relationship between methylation of USP1 gene in peripheral blood and prognosis risk of colorectal cancer [J]. Journal of Practical Oncology, 2019, 33(5): 420-424.
[12]	LI Siwei, PANG Da. Long non-coding RNA(lncRNA)role in cancer [J]. Journal of Practical Oncology, 2019, 33(5): 471-475.
[13]	PU Rui, ZHU Lin, XIA Tingting, BI Haoran, SUN Hongru, HUANG Hao, ZHANG Lei, ZHAO Yashuang. Relationship between the methylation status of CpG island in STAT1,STAT3 gene promoters in peripheral blood and prognosis of colorectal cancer [J]. Journal of Practical Oncology, 2019, 33(4): 346-351.
[14]	FANG Xuan, CHEN Hongsheng, Li Guodong, LIU Ming. Advances in research on treatment of aberrant crypt foci [J]. Journal of Practical Oncology, 2019, 33(4): 376-379.
[15]	SUN Jianghong, HAO Mingzhu, JIANG Dan, GUO Fei, LI Xiaomei. FFDM differential diagnosis of mastitis,benign hyperplasia and breast cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 139-141.

Application progress of liquid biopsy in the diagnosis of colorectal cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments